Doug Drysdale on Advancing Psychedelic Medicine for Mental Health Treatment
Aug 3, 2025
12:00
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
In this Mission Matters episode, Adam Torres interviews Doug Drysdale, CEO of Cybin, about the groundbreaking work his company is doing to develop psychedelic-based treatments for mental health conditions. From clinical trials to regulatory challenges, Doug shares his mission to transform suffering into healing through next-generation therapeutics.